89543-83-9

Basic information

• Product Name: 3-Buten-2-ol, 1-(triphenylmethoxy)-
• CAS NO: 89543-83-9
• Molecular Formula: C23H22O2
• Molecular Weight: 330.426
• Mol File: 89543-83-9.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 3-Buten-2-ol, 1-(triphenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Buten-2-ol, 1-(triphenylmethoxy)-(89543-83-9)
• EPA Substance Registry System: 3-Buten-2-ol, 1-(triphenylmethoxy)-(89543-83-9)

Safety Data

• Hazardous Substances Data: 89543-83-9(Hazardous Substances Data)

Upstream product

• 497-06-3 3,4-butenediol 
• 76-83-5 trityl chloride 
• 1449782-41-5 butyl 2-(trityloxy)acetate 
• 3536-96-7 vinylmagnesium chloride 
• 141561-60-6 ((E)-But-2-enyl)-trityl-ether 
• 213681-85-7 (S)-1-(t-butyldiphenylsiloxy)-2-(1,3-dithian-2-yl)propane 

Downstream Products

• 89543-89-5 1-(3-Phenyl-4,5-dihydro-isoxazol-5-yl)-2-trityloxy-ethanol 
• 942056-39-5 1-(triphenyl-λ⁵-phosphoranylidene)-3-(triphenylmethyloxymethylallyloxy)propan-2-one 
• 1206535-36-5 2-bromoacetic acid 1-trityloxymethylallyl ester 
• 1449782-74-4 diethyl (1Z,3E)-5-(trityloxy)penta-1,3-dienylphosphonate 
• 1391001-97-0 tert-butyl 2-((1-(trityloxy)but-3-en-2-yl)oxy)acetate 
• 1388651-54-4 1-morpholino-2-(1-(trityloxy)but-3-en-2-yloxy)ethanone 
• 1388651-15-7 N-((4aS,5S,7aS)-7a-(2,3-difluorophenyl)-5-((trityloxy)methyl)-4a,5,7,7a-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl)benzamide 
• 1388651-08-8 N-(((3S,4R,5S)-3-(2,3-difluorophenyl)-4-(hydroxymethyl)-5-((trityloxy)methyl)tetrahydrofuran-3-yl)carbamothioyl)benzamide 
• 1388651-58-8 1-(2,3-difluorophenyl)-2-(1-(trityloxy)but-3-en-2-yloxy)ethanone oxime 
• 1388651-55-5 1-(2,3-difluorophenyl)-2-(1-(trityloxy)but-3-en-2-yloxy)ethanone 
• 942056-40-8 1-(triphenyl-λ⁵-phosphoranylidene)but-3-en-2-one 

Relevant articles and documents

FUSED AMINODIHYDROTHIAZINE DERIVATIVES

The present invention relates to a fused aminodihydrothiazine derivative of formula (I): wherein X is hydrogen or fluorine; R is monofluoromethyl or difluoromethyl; and pharmaceutically acceptable salts thereof; which compound has an Aβ production inhibitory effect or a BACE1 inhibitory effect and is useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by Aβ and typified by Alzheimer-type dementia.

FUSED AMINODIHYDROTHIAZINE DERIVATIVES

The present invention relates to a fused aminodihydrothiazine derivative of formula (I): wherein X is hydrogen or fluorine; R is monofluoromethyl or difluoromethyl; and pharmaceutically acceptable salts thereof; which compound has an Αβ production inhibit

Synthesis of 3-oxooxa- and 3-oxoazacycloalk-4-enes by ring-closing metathesis. Application to the synthesis of an inhibitor of cathepsin K

3-Oxooxa- and 3-oxoazacycloalk-4-enes were obtained with good yield from 1-(ω-alkenyloxy)- and 1-(ω-alkenylamino)-but-3-en-2-ones by using a ring-closing metathesis. This methodology has been used to synthesize an inhibitor of cathepsin K.